A Study of mDOT for Immunosuppressant Adherence in Solid Organ Transplant Recipients

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

November 20, 2020

Primary Completion Date

August 31, 2023

Study Completion Date

August 31, 2023

Conditions
Medication AdherenceLiver TransplantationKidney Transplantation
Interventions
OTHER

mHealth intervention

Subjects will receive mHealth direct observation of therapy for 12 weeks

OTHER

standard of care

Subjects will receive standard of care observation for 12 weeks

Trial Locations (2)

21287

Johns Hopkins University, Baltimore

22903

University of Virginia, Charlottesville

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Johns Hopkins University

OTHER

NCT04587024 - A Study of mDOT for Immunosuppressant Adherence in Solid Organ Transplant Recipients | Biotech Hunter | Biotech Hunter